Cargando…
Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
Agitation is a prevalent and difficult-to-treat symptom in patients with moderate-to-severe Alzheimer's disease (AD). Though there are nonpharmacological and pharmacological interventions recommended for the treatment of agitation, the efficacy of these are modest and not always consistent. Fur...
Autores principales: | Ruthirakuhan, Myuri T., Herrmann, Nathan, Gallagher, Damien, Andreazza, Ana C., Kiss, Alexander, Verhoeff, Nicolaas Paul L.G., Black, Sandra E., Lanctôt, Krista L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627000/ https://www.ncbi.nlm.nih.gov/pubmed/31338476 http://dx.doi.org/10.1016/j.conctc.2019.100385 |
Ejemplares similares
-
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019) -
Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
por: Ruthirakuhan, Myuri, et al.
Publicado: (2022) -
A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020) -
The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials
por: Bajtel, Ákos, et al.
Publicado: (2022) -
Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)